Company profile: Amofor
1.1 - Company Overview
Company description
- Provider of formulation development for active ingredients in pharmaceutical, agrochemical, and life science applications.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Amofor
Aster Insights
HQ: United States
Website
- Description: Provider of oncology bioinformatics solutions delivering clinical and molecular data and analytics tools for precision oncology research. Products include Aster Avatar (multimodal dataset with longitudinal clinical and genomic analyses), Aster Galaxy (standardized data library), Aster Navigator (analytics with insights from AI models), Aster Constellation (precision oncology registries and clinical trial matching), and Total Cancer Care®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aster Insights company profile →
Pyxant Labs
HQ: United States
Website
- Description: Provider of GLP bioanalytical chemistry services as a contract research laboratory for life sciences clients, offering bioanalytical method development (validation and optimization), analytical and bioanalytical support for ADME and PK/PD studies, and spatial bioanalysis and spatial biology solutions from discovery through clinical development and NDA approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxant Labs company profile →
Labcorp Drug Development
HQ: United States
Website
- Description: Provider of global contract research and drug development services, delivering early- and late-stage support including drug discovery studies, preclinical and clinical pharmacology, clinical trial execution with patient recruitment and data analysis, biomarker services, oncology research (cell line assays, tumor models), biopharma laboratory services with antibody-drug conjugate capabilities, and cell and gene therapy development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcorp Drug Development company profile →
ZebraSci
HQ: United States
Website
- Description: Provider of inspections, testing, life cycle management, regulatory, and medical device development services for healthcare, specializing in combination product development and testing (pharma packaging and drug stability), drug device design verification, container closure integrity (CCI) testing, silicone characterization for parenteral containers using FlexHD, and drug delivery device selection and evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ZebraSci company profile →
Safety Partners
HQ: United States
Website
- Description: Provider of environmental, health, safety, and regulatory compliance services, including permit and license management, EHS program development and implementation, industrial hygiene, animal care and use support for vivarium setup and compliance, web-based and on-site training, and lab relocation and decommissioning, including permit transfers and decontamination.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Safety Partners company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Amofor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Amofor
2.2 - Growth funds investing in similar companies to Amofor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Amofor
4.2 - Public trading comparable groups for Amofor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →